Lipoprotein(a): A Genetically Determined, Causal, and Prevalent

Lipoprotein(a) and Cardiovascular Disease

Pharmaceuticals, Free Full-Text

Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week - ScienceDirect

The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis, European Journal of Medical Research

Clinical Feature: The ABCs of Lipoprotein(a)

Frontiers Causal effects of genetically predicted type 2 diabetes mellitus on blood lipid profiles and concentration of particle-size-determined lipoprotein subclasses: A two-sample Mendelian randomization study

Lipoprotein(a) and Cardiovascular Risk

Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA) - ScienceDirect

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development

Frontiers Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes

IJMS, Free Full-Text

Cells, Free Full-Text

Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk

Lipoprotein (a) [Lp(a)] levels can be increased due to genetic variants